Cystic Fibrosis Therapeutics Market By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, and CFTR Modulators), By Route of Administration (Oral Drugs and Inhaled Drugs), and By Region - Trends, Analysis, and Forecast till 2029

Report Code: PMI442120 | Publish Date: May 2024 | No. of Pages: 180

Global Cystic Fibrosis Therapeutics Market Companies

  • Hoffmann-La Roche Ltd.
  • Allergan
  • Gilead Sciences, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co. Inc.
  • Novartis AG
  • Alcresta Therapeutics Inc.
  • AstraZeneca Plc.
  • Alaxia

Recent News:

  • Roche Pharmaceuticals has acquired a suite of strength-enhancing compounds from Enterprise Therapeutics, which it plans to develop into drugs for people with cystic fibrosis. These compounds will be developed by Genentech, a member of the Roche group. Unlike other potential agents in development, these drug candidates target TMEM16A, an alternative chloride channel to CFTR in October 2020